New Drug Approved for Lowering Bad Cholesterol

Via Peters

The U.S. Food and Drug Administration (FDA) has approved the distribution and use of Novartis‘ new drug for lowering bad cholesterol. Leqvio (inclisiran) is the first and only small interfering RNA (siRNA) treatment that can reduce low-density lipoprotein cholesterol (LDL). It is intended as an adjunct to maximally tolerated statin therapy and a proper […]